Results 1 to 10 of about 45,910 (249)
Bullous Pemphigoid and Other Pemphigoid Dermatoses [PDF]
Medicina, 2021 The pemphigoid family of dermatoses is characterized by autoimmune subepidermal blistering. The classic paradigm for pemphigoid, and the most common member, is bullous pemphigoid.
Valeryia Pratasava +6 more
doaj +4 more sources
Comorbidity in bullous pemphigoid: up-date and clinical implications
Frontiers in Immunology, 2023 Bullous pemphigoid is the most common autoimmune blistering disease in industrialized countries and particularly affects the elderly. In this patient population, comorbid diseases are frequent and may complicate management and treatment of bullous ...
Johanna Huttelmaier +2 more
doaj +2 more sources
Dyshidrosiform Bullous Pemphigoid [PDF]
Medicina, 2021 Dyshidrosiform bullous pemphigoid is a variant of bullous pemphigoid. At least 84 patients with dyshidrosiform bullous pemphigoid have been described. Dyshidrosiform bullous pemphigoid usually presents with pruritic blisters in elderly individuals; the ...
Philip R. Cohen
doaj +3 more sources
New-onset bullous pemphigoid following the fifth dose of the COVID-19 vaccine Pfizer-BioNTech: A case report [PDF]
SAGE Open Medical Case ReportsBullous pemphigoid is recognized as the most prevalent autoimmune blistering skin disease. This report presents a case of a 54-year-old male in Canada who developed new-onset bullous pemphigoid 4 weeks after receiving his fifth COVID-19 vaccine booster ...
Eman Badawod
doaj +2 more sources
BMC Endocrine Disorders, 2021 Background Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid.
Vaia Lambadiari +10 more
doaj +2 more sources
Acta Dermato-Venereologica, 2021 Bullous pemphigoid constitutes a rare dermatological immune-related adverse event of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors.
Aikaterini Tsiogka +2 more
doaj +2 more sources
A Systematic Review of Drug-Induced Pemphigoid
Acta Dermato-Venereologica, 2020 Bullous pemphigoid is an autoimmune subepithelial disease characterised by pruritus followed by urticarial plaques and finally bullae on the skin and mucosa.
Matthew J. Verheyden +2 more
doaj +2 more sources
Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients [PDF]
Anais Brasileiros de Dermatologia, 2014 BACKGROUND: aAlthough rare, bullous pemphigoid (BP) is the most common autoimmune blistering disease. Recent studies have shown that patients with bullous pemphigoid are more likely to have neurological and psychiatric diseases, particularly prior to the
Vera Barreto Teixeira +4 more
doaj +4 more sources
Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report [PDF]
SAGE Open Medical Case ReportsBullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality.
Sarah S. Rashid +2 more
doaj +2 more sources
Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid
Acta Dermato-Venereologica, 2023 Current research on the malignancy rate and spectrum of malignancies in patients with bullous pemphigoid is contradictory. The aims of this study were to determine the prevalence and spectrum of malignancy in patients with bullous pemphigoid and to ...
Sharon Baum +4 more
doaj +1 more source